David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 3,905 shares at $57.38 ($223K) on 2023-12-19, disclosed to the SEC on 2023-12-20.
Open-market sale of $223k APLS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.00 | 1,605 | $91K | 40.9% |
| 2 | $57.38 | 2,300 | $132K | 59.1% |
| Total | $57.22 avg | 3,905 | $223K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |